Newborn screening for Fabry disease by measuring GLA activity using tandem mass spectrometry
- 9 October 2010
- journal article
- research article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 411 (19-20), 1428-1431
- https://doi.org/10.1016/j.cca.2010.03.009
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Implementation of newborn screening for Krabbe disease: Population study and cutoff determinationClinical Biochemistry, 2009
- Newborn Screening for Krabbe Disease: the New York State ModelPediatric Neurology, 2009
- Characterization of Fabry Disease in 352 Pediatric Patients in the Fabry RegistryPediatric Research, 2008
- Fabry's diseaseThe Lancet, 2008
- Newborn Screening for Pompe Disease by Measuring Acid α-Glucosidase Activity Using Tandem Mass SpectrometryClinical Chemistry, 2008
- Newborn screening for lysosomal storage disordersMolecular Genetics and Metabolism, 2006
- High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening*American Journal of Human Genetics, 2006
- Direct Multiplex Assay of Lysosomal Enzymes in Dried Blood Spots for Newborn ScreeningClinical Chemistry, 2004
- Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous malesJournal of Medical Genetics, 2001
- Enzymatic Defect in Fabry's DiseaseThe New England Journal of Medicine, 1967